{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:32:50Z","timestamp":1780374770733,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Associazione Italiana per la Ricerca sul CancroAssociazione Italiana per la Ricerca sul Cancro","award":["15460"],"award-info":[{"award-number":["15460"]}]},{"name":"Italian Ministry of Health"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jaad.2018.07.060","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T09:34:50Z","timestamp":1538127290000},"page":"1263-1271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients"],"prefix":"10.1016","volume":"80","author":[{"given":"Bruna","family":"Dalmasso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Pastorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ciccarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Andreotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Grillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Mastracci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Spagnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ballestrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Queirolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ghiorzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2018.07.060_bib1","unstructured":"Associazione Italiana di Oncologia Medica. Linee guida melanoma. Available at: https:\/\/www.aiom.it\/linee-guida\/melanoma. Accessed April 27, 2018."},{"key":"10.1016\/j.jaad.2018.07.060_bib2","unstructured":"Associazione Italiana di Oncologia Medica. I numeri del cancro in Italia. Available at: https:\/\/pensiero.it\/catalogo\/libri\/numeri-del-cancro-italia. Accessed April 27, 2018."},{"key":"10.1016\/j.jaad.2018.07.060_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2009.03.016","article-title":"Selection criteria for genetic assessment of patients with familial melanoma","volume":"61","author":"Leachman","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.07.060_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jaad.2015.09.053","article-title":"Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup","volume":"74","author":"Bruno","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.07.060_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10555-017-9661-5","article-title":"Identification, genetic testing, and management of hereditary melanoma","volume":"36","author":"Leachman","year":"2017","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.jaad.2018.07.060_bib6","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.1158\/0008-5472.CAN-06-0494","article-title":"High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL","volume":"66","author":"Goldstein","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2018.07.060_bib7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ijc.22712","article-title":"Cutaneous phenotype and MC1R variants as modifying factors for\u00a0the\u00a0development of melanoma in CDKN2A G101W mutation carriers from 4 countries","volume":"121","author":"Goldstein","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2018.07.060_bib8","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1158\/1078-0432.CCR-08-0403","article-title":"Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families","volume":"14","author":"de Snoo","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2018.07.060_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/(SICI)1097-0215(19991112)83:4<441::AID-IJC2>3.0.CO;2-R","article-title":"Characterization of Ligurian melanoma families and risk of occurrence of other neoplasia","volume":"83","author":"Ghiorzo","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2018.07.060_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/jmedgenet-2011-100281","article-title":"CDKN2A is the main susceptibility gene in Italian pancreatic cancer families","volume":"49","author":"Ghiorzo","year":"2012","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaad.2018.07.060_bib11","doi-asserted-by":"crossref","first-page":"10778","DOI":"10.3748\/wjg.v20.i31.10778","article-title":"Genetic predisposition to pancreatic cancer","volume":"20","author":"Ghiorzo","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaad.2018.07.060_bib12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/1097-0215(20000915)87:6<809::AID-IJC8>3.0.CO;2-U","article-title":"Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden)","volume":"87","author":"Vasen","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2018.07.060_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/annonc\/mdg498","article-title":"INK4\/ARF germline alterations in pancreatic cancer patients","volume":"15","author":"Ghiorzo","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2018.07.060_bib14","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1200\/JCO.2007.13.5624","article-title":"Predicting the risk of pancreatic cancer: on CDKN2A mutations in the melanoma-pancreatic cancer syndrome in Italy","volume":"25","author":"Ghiorzo","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2018.07.060_bib15","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/jnci\/94.12.894","article-title":"Geographical variation in the penetrance of CDKN2A mutations for melanoma","volume":"94","author":"Bishop","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2018.07.060_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmedgenet-2015-103150","article-title":"Melanoma genetics","volume":"53","author":"Read","year":"2016","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaad.2018.07.060_bib17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/jmedgenet-2014-102320","article-title":"High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families","volume":"51","author":"Helgadottir","year":"2014","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaad.2018.07.060_bib18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/ejhg.2010.198","article-title":"Prevalence of\u00a0CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling","volume":"19","author":"McWilliams","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jaad.2018.07.060_bib19","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1086\/323412","article-title":"MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations","volume":"69","author":"Box","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaad.2018.07.060_bib20","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1600-0625.2012.01549.x","article-title":"MC1R variation and melanoma risk in relation to host\/clinical and environmental factors in CDKN2A positive and negative melanoma patients","volume":"21","author":"Ghiorzo","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2018.07.060_bib21","doi-asserted-by":"crossref","first-page":"945","DOI":"10.6004\/jnccn.2016.0101","article-title":"NCCN guidelines insights: melanoma, version 3.2016","volume":"14","author":"Coit","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jaad.2018.07.060_bib22","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jaad.2016.11.051","article-title":"Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile\u2013based classification","volume":"76","author":"Ferris","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.07.060_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw135","article-title":"Germline CDKN2A mutation status and survival in familial melanoma cases","volume":"108","author":"Helgadottir","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2018.07.060_bib24","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jaad.2017.05.050","article-title":"Cancer risks and survival in patients with multiple primary melanomas: association with family history of melanoma and germline CDKN2A mutation status","volume":"77","author":"Helgadottir","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.07.060_bib25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/ajmg.10137","article-title":"High prevalence of the G101W germline mutation in the CDKN2A (p16INK4a) gene in 62 Italian malignant melanoma families","volume":"107","author":"Mantelli","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jaad.2018.07.060_bib26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00008390-200412000-00002","article-title":"Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients","volume":"14","author":"Mantelli","year":"2004","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jaad.2018.07.060_bib27","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jaad.2009.03.039","article-title":"Clinical genetic testing for familial melanoma in Italy: a cooperative study","volume":"61","author":"Bruno","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.07.060_bib28","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2018.07.060_bib29","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1093\/hmg\/ddl199","article-title":"Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma","volume":"15","author":"Ghiorzo","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaad.2018.07.060_bib30","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1755-148X.2012.00982.x","article-title":"Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study","volume":"25","author":"Davies","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2018.07.060_bib31","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2016"},{"key":"10.1016\/j.jaad.2018.07.060_bib32","series-title":"A Package for Survival Analysis in S","author":"Therneau","year":"2015"},{"issue":"22","key":"10.1016\/j.jaad.2018.07.060_bib33","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/bioinformatics\/btr511","article-title":"survcomp: an R\/Bioconductor package for performance assessment and comparison of survival models","volume":"27","author":"Schroeder","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaad.2018.07.060_bib34","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamadermatol.2014.514","article-title":"Detection of primary melanoma in individuals at extreme high risk","volume":"150","author":"Moloney","year":"2014","journal-title":"JAMA Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218323673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218323673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:50:55Z","timestamp":1759272655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218323673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0190962218323673"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.07.060","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.07.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}